Vitrolife AB (OSTO:VITR) Total Current Assets : kr2,110 Mil (As of Sep. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Vitrolife AB Total Current Assets?

Total current assets includes Cash, Cash Equivalents, Marketable Securities, Total Receivables, Total Inventories, and Other Current Assets. Vitrolife AB's total current assets for the quarter that ended in Sep. 2024 was kr2,110 Mil.

Vitrolife AB Total Current Assets Historical Data

The historical data trend for Vitrolife AB's Total Current Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vitrolife AB Total Current Assets Chart

Vitrolife AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Current Assets

Get a 7-Day Free Trial

1,150.22

1,414.44

1,407.00

1,572.00

1,914.00

Vitrolife AB Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Current Assets	Get a 7-Day Free Trial															1,825.00	1,914.00	2,048.00	1,998.00	2,110.00

Vitrolife AB Total Current Assets Calculation

Total Current Assets are the asset that can be converted to cash or used to pay current liabilities within 12 months.

Vitrolife AB's Total Current Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	861	+	537	+	413	+	103
	=	1,914

Vitrolife AB's Total Current Assets for the quarter that ended in Sep. 2024 is calculated as

Total Current Assets	=	Cash, Cash Equivalents, Marketable Securities	+	Total Receivables	+	Total Inventories	+	Other Current Assets
	=	925	+	746	+	403	+	36
	=	2,110

Total Current Assets is linked to the Current Ratio, which is the result of dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations.

Total Current Assets is also linked to Working Capital, Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Vitrolife AB (OSTO:VITR) Total Current Assets Explanation

In Ben Graham's calculation of liquidation value, inventory is only considered worth half of its book value, and accounts receivable is considered worth 75% of its value. Therefore the liquidation value is lower than calculated from total current assets.

Vitrolife AB's Liquidation Value for the quarter that ended in Sep. 2024 is

	Liquidation value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	925	-	3745	+	0.75 * 617	+	0.5 * 403
=	-2,156

Vitrolife AB Total Current Assets Related Terms

Thank you for viewing the detailed overview of Vitrolife AB's Total Current Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Vitrolife AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vitrolife AB (OSTO:VITR) » Definitions » Total Current Assets

Comparable Companies

Traded in Other Exchanges

VTRLY:USA 0YAY:UK VTFN:Germany

Address

Box 9080, Gothenburg, SWE, 400 92

Website

https://www.vitrolife.com

Vitrolife AB provides medical devices and genetic testing services intended for the reproductive-health market in the field of reproductive health. The company develops, manufactures, and distributes medical devices and provides genetic testing services for IVF clinics and their patients. Its mission is to support IVF clinics (in vitro fertilization) in enhancing their practice as well as the outcome of a patient's fertility treatment, thereby enabling patients to receive support to navigate the complexities of reproductive health through successful outcomes and patient satisfaction. The group has three geographical segments EMEA, Americas and APAC, out of which it derives maximum revenue from EMEA.

Vitrolife AB Headlines

No Headlines